Time in Range — Feasibility of DPP-4 Inhibitor Therapy on Advanced Hybrid Closed Loop System
Citation(s)
Feasibility of DPP-4 Inhibitor for the Treatment of Iftar-Related Glycemic Excursions in Patients With Type 1 Diabetes on MiniMedâ„¢ 780G Advanced Hybrid Closed Loop System